Skip to main content
. 2018 Apr 18;154(5):569–573. doi: 10.1001/jamadermatol.2018.0212

Table 2. Characteristics of Skin Cancer Screening Visits by Clinician Type Based on 33 647 Unique Visits.

Visit-Level Patient Characteristic No. (%) of Visits P Valuea
All Clinicians PA Only Dermatologist Only
No. of visits 33 647 17 162 (51.0) 16 485 (49.0) NA
Sex .12
Male 13 657 (40.6) 6895 (40.2) 6762 (41.0)
Female 19 990 (59.4) 10 267 (59.8) 9723 (59.0)
Age, mean (SD), y 55.5 (17.1) 56.2 (17.0) 54.8 (17.2) <.001
Personal history of melanoma 3572 (10.6) 1644 (9.6) 1928 (11.7) <.001
History of any skin cancer 13 120 (39.0) 7689 (44.8) 5431 (32.9) <.001
Outcome
Total biopsies performed 7355 (21.9) 3928 (22.9) 3427 (20.8) <.001
Biopsy of pigmented lesions 4039 (12.0) 2213 (12.9) 1826 (11.1) <.001
NMSC diagnosed 2024 (6.1) 1031 (6.1) 993 (6.1) .98
Melanoma diagnosed
In situ (% visits) 98 (0.3) 40 (0.2) 58 (0.4) .04
Invasive (% visits) 51 (0.2) 26 (0.2) 25 (0.2) >.99
Breslow depth, median (IQR), mm 0.42 (0.3-0.63) 0.41 (0.29-0.59) 0.44 (0.35-0.76) .36
Breslow depth, mean (SD), mm 0.72 (1.25) 0.86 (1.72) 0.58 (0.32) .44

Abbreviations: IQR, interquartile range; NA, not applicable; NMSC, nonmelanoma skin cancer; PA, physician assistant.

a

P value compares data for dermatologist only with data for PA only.